lamivudine has been researched along with Acute Disease in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (10.53) | 18.2507 |
2000's | 57 (75.00) | 29.6817 |
2010's | 11 (14.47) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buzzetti, E; Davidson, BR; Gurusamy, KS; Mantzoukis, K; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E | 1 |
Jie, YS; Ke, WM; Lai, J; Sun, HX; Zhang, K | 1 |
Li, SC; Sun, LJ; Yu, JW; Zhao, YH | 1 |
Alessandrelli, F; Azzaroli, F; Buonfiglioli, F; Lisotti, A; Mazzella, G; Montagnani, M | 1 |
Boulos, MI; Guastini, CM; Tuon, FF | 1 |
Chen, JJ; Koay, LB; Kuo, HT; Lee, C; Lin, CY; Sheu, MJ; Tang, LY; Tsai, SL | 1 |
Boricić, I; Delić, D; Nesić, Z; Prostran, M; Svirtlih, N | 1 |
Bocket, L; Boulanger, L; Canva, V; Coursier, J; Dharancy, S; Dieu, E; Gonzalez, F; Mathurin, P | 1 |
Acar, A; Aydin, A; Eken, A; Eyigün, CP; Görenek, L; Pahsa, A; Sayal, A | 1 |
Kang, P; Li, SC; Sun, LJ; Yu, JW; Zhao, YH | 2 |
Goto, H; Hayashi, K; Hirooka, Y; Ishigami, M; Itoh, A; Katano, Y; Kumada, T; Nakano, I; Toyoda, H; Yano, M; Yoshioka, K | 1 |
Locarnini, S | 1 |
Chiba, T; Nakanishi, Y; Seno, H; Yamashita, Y | 1 |
Ahn, JH; Ahn, SH; Gong, G; Jung, KH; Kim, SB; Sohn, BS; Son, BH | 1 |
García-Alonso, FJ; Martín-Mateos, RM; Moreira Vicente, V | 1 |
Babiker, ZOE; Hogan, C; Ustianowski, A; Wilkins, E | 1 |
Baxa, DM; Borroto-Esoda, K; Chappell, BJ; Golembieski, A; Gordon, SC; Jovanovich, J; Kizy, A; Krishnan, PV; Sharif, O; Shetron-Rama, L; Snow-Lampart, A; Thekdi, AD | 1 |
Asahina, Y; Hamano, K; Itakura, J; Izumi, N; Kanazawa, N; Kawamura, S; Miyake, S; Noguchi, O; Sakai, T; Tsuchiya, K; Uchihara, M | 1 |
Changchien, CS; Chen, TM; Lee, CM; Liao, CA; Lu, SN; Ong, GY; Tung, HD; Wang, JH | 1 |
Broelsch, CE; Gerken, G; Karliova, M; Malago, M; Rothaar, T; Treichel, U; Trippler, M; Valentin-Gamazo, C | 1 |
Cevreska, L; Efremov, DG; Georgievski, B; Panovska, I; Pivkova, A | 1 |
Kirchner, JT; Lin, KW | 1 |
Imazeki, F; Kanda, T; Nagao, K; Saisho, H; Suzuki, Y; Yokosuka, O; Yoshida, S | 1 |
Amuca, H; Cakir, B; Dökmeci, G; Karahan, N; Soylu, AR; Tezel, A; Umit, H | 1 |
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Saitoh, S; Sato, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
Cho, YS; Lee, CK; Park, IS; Suh, JH; Won, SY | 1 |
Maggiolo, F; Ripamonti, D; Suter, F | 1 |
Han, BH; Lee, SU; Lim, HJ; Park, CB; Yun, BC | 1 |
Kondili, LA; Mutimer, D; Osman, H | 1 |
Käser, L; Kolyvanos Naumann, U; Vetter, W | 1 |
Fujiwara, K; Mochida, S | 1 |
Yoshiba, M | 1 |
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
Ackerman, Z; Ben-Ari, Z; Lurie, Y; Reshef, R; Rosner, G; Safadi, R; Sbeit, W; Schmilovitz-Weiss, H; Sikuler, E; Tur-Kaspa, R; Zuckerman, E | 1 |
Chien, RN; Hsieh, SY; Kuo, MC; Liaw, YF; Shih, LY; Wang, PN; Yeh, CT | 1 |
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
Chen, PM; Chiou, TJ; Hsiao, LT; Lee, MY; Lin, PC; Poh, SB | 1 |
Shah, SR | 1 |
Eun, JR | 1 |
Chen, JJ; Koay, LB; Kuo, HT; Lee, C; Lin, CY; Sheu, MJ; Sun, CS; Tang, LY; Tsai, SL | 1 |
Ahlenstiel, G; Altfeld, M; Kaufmann, DE; Kupfer, B; Lichterfeld, M; Mui, SK; Rockstroh, JK; Spengler, U; Vogel, M; Voigt, E; Walker, B | 1 |
Das, K; Hissar, S; Kumar, M; Monga, R; Pande, C; Sarin, SK; Satapathy, S; Sharma, BC | 1 |
Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Itoh, A; Katano, Y; Kumada, T; Nakano, I; Takeda, Y; Toyoda, H; Yano, M; Yoshioka, K | 1 |
Ishikawa, S; Iwasaki, Y; Kato, J; Kobashi, H; Miyake, Y; Nawa, T; Sakaguchi, K; Shiratori, Y; Takaki, A; Tatsukawa, M | 1 |
Kloudová, A; Mrázek, J; Orságová, I; Roznovský, L | 1 |
Bader, TF; Fazili, J; Tierney, W | 1 |
Akuta, N; Arase, Y; Chihara, N; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Watahiki, S; Yatsuji, H | 1 |
Bahr, MJ; Cornberg, M; Deterding, K; Hadem, J; Manns, MP; Metzler, F; Pothakamuri, SV; Schlaphoff, V; Wedemeyer, H | 1 |
Adler, G; Dikopoulos, N; Hasel, C; Seufferlein, T; Zizer, E | 1 |
Girke, J; Manns, MP; Tillmann, HL; Wedemeyer, H; Wiegand, J | 1 |
Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Riezu-Boj, JI; Sangro, B; Sola, I | 1 |
Aquilina, C; Roueire, A; Viraben, R | 1 |
Battegay, M; Bisset, LR; Cone, RW; Grob, PJ; Huber, W; Opravil, M; Vernazza, PL; Weber, R | 1 |
Andreone, P; Belli, L; Bernardi, M; Caraceni, P; Cavallari, A; D'Errico, A; Dal Monte, PR; Ercolani, G; Forti, D; Grazi, GL; Ideo, G; Jovine, E; Mazziotti, A; Milandri, GL | 1 |
Ahmed, A; Keeffe, EB | 1 |
Mazzola, M; Pastore, G; Santantonio, T | 1 |
Dulai, G; Higa, L; Kobashigawa, J; Martin, P | 1 |
Ap, S; Berrey, MM; Brown, DJ; Corey, L; Huang, Y; Malhotra, U; Markee, J; McElrath, MJ; Musey, L; Schacker, T | 1 |
Campi, G; Casorati, G; Corey, L; Demarest, JF; Kaufmann, D; Lazzarin, A; Lenge, C; Pantaleo, G; Rizzardi, GP; Soudeyns, H; Tambussi, G | 1 |
Conway, B; Fransen, S; Mayers, DL; Montaner, JS; Montessori, V; O'Shaughnessy, MV; Rouleau, D; Shillington, A; Weislow, O | 1 |
Bucy, RP; Gnann, JW; Goepfert, PA; Kilby, JM; Miller, AP; Saag, MS; Sillers, M | 1 |
Reshef, R; Sbeit, W; Tur-Kaspa, R | 1 |
de Man, RA; Osterhaus, AD; Pontesilli, O; Uytdehaag, F; van Nunen, AB | 1 |
Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Kumada, H; Murashima, N; Saitoh, S; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
Forns, X; Sánchez-Tapias, JM | 1 |
Gupta, S; Jaffe, M; Piraka, C | 1 |
Chen, RW; Koskela, P; Lappalainen, M; Piiparinen, H; Sarna, S; Seppänen, M | 1 |
Alba, L; Antinori, A; Grisetti, S; Liuzzi, G; Sette, P; Zaccarelli, M | 1 |
Cane, P; Feraz-Neto, BH; Harrison, R; Mutimer, D; O'Donnell, K; Pillay, D; Shaw, J | 1 |
Balducci, M; Clementi, M; Manzin, A; Petrelli, E; Pieretti, C; Rocchi, MB | 1 |
Eng, HL; Lee, CM; Liao, CA; Lu, SN; Wang, MC; Wu, HC | 1 |
Changchien, CS; Chen, CH; Hung, CH; Lee, CM; Lu, SN; Wang, JH | 1 |
Ray, SC; Sulkowski, MS; Thomas, DL | 1 |
Di Perri, G; Maiello, A; Quario, M; Racca, D; Sinicco, A; Zeme, DA | 1 |
de Man, RA; Doorduijn, JK; Janssen, HL; Niesters, HG; Schalm, SW; van der Eijk, AA | 1 |
8 review(s) available for lamivudine and Acute Disease
Article | Year |
---|---|
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
Topics: Acute Disease; Antiviral Agents; Disease Progression; Guanine; Hepatic Encephalopathy; Hepatitis B; Hepatitis C, Chronic; Humans; Immunization, Passive; Interferons; Lamivudine; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors | 2017 |
[Pharmacological treatment of acute hepatitis B].
Topics: Acute Disease; Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Spain; Telbivudine; Tenofovir; Thymidine; Treatment Outcome | 2012 |
Hepatitis B.
Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Patient Selection; Recombinant Proteins; Reverse Transcriptase Inhibitors; Risk Factors; Sexually Transmitted Diseases; Substance Abuse, Intravenous; United States; Vaccination | 2004 |
[Hepatitis B (acute and chronic)].
Topics: Acute Disease; Adenine; Adolescent; Adult; Antiviral Agents; Child; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Organophosphonates; Prognosis; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors | 2004 |
[Advances in the treatment of acute hepatitis B].
Topics: Acute Disease; Anticoagulants; Antiviral Agents; Carrier State; Clinical Trials as Topic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Interferons; Lamivudine | 2004 |
[Recent advances in the treatment of fulminant hepatitis B].
Topics: Acute Disease; Antiviral Agents; Carrier State; Cyclosporine; Drug Therapy, Combination; Guanine; Hemodiafiltration; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Liver Failure, Acute; Liver Transplantation; Methylprednisolone; Plasma Exchange; Prognosis; Pulse Therapy, Drug | 2004 |
Understanding hepatitis B.
Topics: Acute Disease; Adenine; Algorithms; Antiviral Agents; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Organophosphonates; Recombinant Proteins | 2005 |
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.
Topics: Acute Disease; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chronic Disease; Disease Progression; Drug Therapy, Combination; Fever; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Syndrome; Viral Load; Zidovudine | 2000 |
8 trial(s) available for lamivudine and Acute Disease
Article | Year |
---|---|
Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
Topics: Acute Disease; Adult; Antiviral Agents; Female; Forecasting; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Models, Biological; Plasma Exchange; Predictive Value of Tests; Prognosis; Severity of Illness Index | 2008 |
Lamivudine monotherapy for chronic hepatitis B infection with acute exacerbation revisited.
Topics: Acute Disease; Adult; Antiviral Agents; Drug Administration Schedule; Female; Follow-Up Studies; Genotype; Hepatitis A virus; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Remission Induction; Young Adult | 2009 |
The study of efficacy of lamivudine in patients with severe acute hepatitis B.
Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Proportional Hazards Models | 2010 |
Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation.
Topics: Acute Disease; Adolescent; Adult; Alanine Transaminase; Female; Follow-Up Studies; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Predictive Value of Tests; Recurrence; Reverse Transcriptase Inhibitors | 2002 |
[Adequacy of immediate Lamivudine trial for chronic hepatitis B patients with acute exacerbation].
Topics: Acute Disease; Adolescent; Adult; Anti-HIV Agents; Female; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged | 2004 |
Lamivudine treatment for acute severe hepatitis B: a pilot study.
Topics: Acute Disease; Adult; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Humans; Immunocompromised Host; Lamivudine; Male; Pilot Projects; Polymerase Chain Reaction; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
A randomized controlled trial of lamivudine to treat acute hepatitis B.
Topics: Acute Disease; Adolescent; Adult; Aged; Bilirubin; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome | 2007 |
[Lamivudine therapy in patients with severe acute hepatitis B].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Male; Middle Aged | 2007 |
60 other study(ies) available for lamivudine and Acute Disease
Article | Year |
---|---|
Serum HBsAg level and its clinical significance in lamivudine treatment for patients with HBeAg-negative acute-on-chronic liver failure.
Topics: Acute Disease; Adult; Antiviral Agents; Biomarkers; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome | 2014 |
Lamivudine treatment for severe acute HBV hepatitis.
Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Male; Middle Aged | 2008 |
Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis.
Topics: Acute Disease; Hepatitis B, Chronic; Humans; Hyperamylasemia; Lamivudine; Male; Middle Aged; Pancreatitis; Reverse Transcriptase Inhibitors | 2008 |
Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged | 2009 |
[Hepatitis B viral infection treated with lamivudine during pregnancy].
Topics: Acute Disease; Adult; Female; Hepatitis B; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious | 2009 |
[Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Topics: Acute Disease; Adult; Alanine Transaminase; Antioxidants; Antiviral Agents; Aspartate Aminotransferases; Carrier State; Case-Control Studies; Drug Therapy, Combination; Female; Glutathione Peroxidase; Hepatitis B; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver; Male; Malondialdehyde; Oxidative Stress; Superoxide Dismutase | 2009 |
Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
Topics: Acute Disease; Adult; Antiviral Agents; China; Cohort Studies; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Viral Load | 2010 |
Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation; Phenotype; Prevalence; Severity of Illness Index; Young Adult | 2010 |
Transmission of antiviral drug resistant hepatitis B virus: implications for public health and patient management.
Topics: Acute Disease; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Phenotype; Prevalence; Public Health; Severity of Illness Index; Treatment Outcome | 2010 |
Education and imaging. Hepatobiliary and pancreatic: multiple sexually transmitted infections.
Topics: Acute Disease; Anti-Infective Agents; Antiprotozoal Agents; Antiviral Agents; Colonoscopy; Entamoebiasis; Gastrointestinal Hemorrhage; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Immunoglobulin M; Jaundice; Lamivudine; Male; Metronidazole; Middle Aged; Penicillins; Rectum; Syphilis Serodiagnosis; Syphilis, Cutaneous; Unsafe Sex | 2010 |
Updated longitudinal data on acute exacerbation of chronic hepatitis B in patients with breast cancer receiving anthracycline-based adjuvant chemotherapy: therapeutic vs. pre-emptive use of lamivudine.
Topics: Acute Disease; Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Logistic Models; Longitudinal Studies; Medical Records; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Taxoids; Treatment Outcome | 2011 |
Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?
Topics: Acute Disease; Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Lamivudine; Male; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Young Adult | 2012 |
Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.
Topics: Acute Disease; Adenine; Adult; Antiviral Agents; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Male; Mutation; Organophosphonates; Retrospective Studies; Sequence Analysis, DNA; United States | 2013 |
[Ulcerative colitis developed after acute exacerbation of chronic hepatitis B].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Hepatitis B, Chronic; Humans; Lamivudine; Male; Prednisolone | 2002 |
Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.
Topics: Acute Disease; Adult; Base Sequence; DNA Primers; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Retrospective Studies; Time Factors | 2002 |
Lamivudine treatment for acute hepatitis B virus infection during allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adult; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2003 |
Corticosteroids and lamivudine combined to treat acute severe flare-up in a chronic hepatitis B and C patient.
Topics: Acute Disease; Aged; Antiviral Agents; Betamethasone; Drug Therapy, Combination; Glucocorticoids; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lamivudine; Male; Prednisolone | 2004 |
Lamivudine-induced acute pancreatitis in a patient with decompensated Hbv-related chronic liver disease.
Topics: Acute Disease; Aged; Amylases; Fatal Outcome; Hepatitis B, Chronic; Humans; Lamivudine; Male; Pancreatitis; Reverse Transcriptase Inhibitors | 2004 |
Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B.
Topics: Acute Disease; Adult; Aged; Amino Acid Motifs; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors | 2004 |
HIV-1 and hepatitis B virus: time for a re-think?
Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; HIV-1; Humans; Lamivudine; Male | 2004 |
[The clinical meaning of the emergence of viral breakthrough during lamivudine treatment in patients with hepatitis B virus related chronic liver disease].
Topics: Acute Disease; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2004 |
The use of lamivudine for patients with acute hepatitis B (a series of cases).
Topics: Acute Disease; Adult; Aged; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Renal Dialysis; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome | 2004 |
Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection.
Topics: Acute Disease; Adult; Cohort Studies; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Treatment Outcome | 2004 |
Acute leukaemia in chronic hepatitis B patients with lamivudine therapy.
Topics: Acute Disease; Adult; Female; Hepatitis B, Chronic; Humans; Lamivudine; Leukemia, Myeloid; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2004 |
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.
Topics: Acute Disease; Administration, Oral; Adult; Bilirubin; Biomarkers; Disease Progression; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Failure, Acute; Male; Middle Aged; Prognosis; Radiography; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Transaminases; Treatment Outcome; Ultrasonography | 2005 |
Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients.
Topics: Acute Disease; Adult; Anti-HIV Agents; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male | 2005 |
[Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy in acute exacerbation after viral breakthrough during lamivudine therapy in chronic hepatitis B].
Topics: Acute Disease; Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates | 2006 |
Nonresponse to 18-month lamivudine monotherapy in chronic hepatitis B patients with dual genotype B and C infection and acute exacerbation.
Topics: Acute Disease; Antiviral Agents; DNA, Viral; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine | 2006 |
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Follow-Up Studies; Histocompatibility Testing; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Retrospective Studies; RNA, Viral; Stavudine; Treatment Outcome; Zidovudine | 2006 |
Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan.
Topics: Acute Disease; Adolescent; Adult; Aged; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation; Odds Ratio; Reverse Transcriptase Inhibitors; Species Specificity; Viral Proteins | 2007 |
A homosexual Japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis.
Topics: Acute Disease; Adult; Antiprotozoal Agents; Asian People; Dysentery, Amebic; Genotype; Hepatitis B; Hepatitis B virus; Homosexuality, Male; Humans; Lamivudine; Male; Metronidazole; Reverse Transcriptase Inhibitors | 2007 |
Treating acute hepatitis B.
Topics: Acute Disease; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2007 |
Prolonged hepatitis after acute infection with genotype H hepatitis B virus.
Topics: Acute Disease; Antiviral Agents; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Male; Middle Aged; Salvage Therapy; Treatment Failure | 2007 |
Clearance of chronic HCV infection during acute delta hepatitis.
Topics: Acute Disease; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Hepatitis B; Hepatitis C, Chronic; Hepatitis D; Humans; Lamivudine; Liver Function Tests; Male; Substance Abuse, Intravenous; Superinfection | 2009 |
[A 40-year-old female patient with seronegative autoimmune hepatitis following a newly acquired hepatitis B infection].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Autoimmunity; Biopsy; Female; Glucocorticoids; Hepatitis B; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Lamivudine; Liver; Prednisolone; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome | 2008 |
[Acute hepatitis B: is antiviral therapy indicated? Two case reports].
Topics: Acute Disease; Adenine; Adult; Algorithms; Antiviral Agents; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Middle Aged; Organophosphonates; Prothrombin Time; Transaminases; Treatment Failure; Treatment Outcome | 2008 |
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
Topics: Acute Disease; Bilirubin; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Transaminases | 1998 |
Acute generalized exanthematous pustulosis: a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor.
Topics: Acute Disease; Adult; Anti-HIV Agents; Diagnosis, Differential; Drug Eruptions; Exanthema; HIV Infections; Humans; Lamivudine; Male; Protease Inhibitors; Skin Diseases, Vesiculobullous; Zidovudine | 1998 |
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
Topics: Acute Disease; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation; Biomarkers; Female; HIV Infections; HLA-DR Antigens; Humans; Lamivudine; Leukocyte Common Antigens; Lymphocyte Activation; Lymphocyte Count; Male; Membrane Glycoproteins; NAD+ Nucleosidase; Prospective Studies; Ritonavir; RNA, Viral; T-Lymphocytes; Viral Load; Zidovudine | 1998 |
Lamivudine treatment for acute hepatitis B after liver transplantation.
Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence | 1998 |
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
Topics: Acute Disease; Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Follicular; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation | 1999 |
Lamivudine is safe and effective in fulminant hepatitis B.
Topics: Acute Disease; Adult; Antineoplastic Agents; Hepatitis B; Humans; Lamivudine; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Inhibitors | 1999 |
Successful use of lamivudine for severe acute hepatitis B virus infection in a cardiac transplant recipient.
Topics: Acute Disease; Antiviral Agents; Heart Transplantation; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors | 1999 |
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection.
Topics: Acute Disease; Adult; Anti-HIV Agents; Candida; CD4 Lymphocyte Count; Chronic Disease; Cytokines; Cytotoxicity, Immunologic; Drug Therapy, Combination; Female; HIV Antigens; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; T-Lymphocytes; Tetanus Toxoid; Viral Load; Zidovudine | 2000 |
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.
Topics: Acute Disease; Anti-HIV Agents; Clone Cells; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Saquinavir; T-Lymphocytes, Cytotoxic; Viremia; Zidovudine | 2000 |
Primary lamivudine resistance in acute/early human immunodeficiency virus infection.
Topics: Acute Disease; Adult; Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Viral Load | 1999 |
Lamivudine in the treatment of acute hepatitis B.
Topics: Acute Disease; Aged; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2000 |
Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.
Topics: Acute Disease; Antiviral Agents; Cells, Cultured; DNA, Viral; Hepatitis A; Hepatitis B Core Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatovirus; Humans; Interferon-gamma; Lamivudine; Lymphocyte Activation; Male; Superinfection; Viral Interference; Virus Replication | 2001 |
Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study.
Topics: Acute Disease; Adult; Alanine Transaminase; Bilirubin; DNA, Viral; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Pilot Projects; Prothrombin Time; Reverse Transcriptase Inhibitors | 2001 |
[Laboratory diagnosis of hepatitis B].
Topics: 2-Aminopurine; Acute Disease; Antiviral Agents; DNA Replication; DNA, Viral; Drug Resistance; Famciclovir; Genetic Variation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lamivudine; Virus Replication | 2001 |
Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B.
Topics: Acute Disease; Adult; Antiviral Agents; Combined Modality Therapy; Female; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Plasmapheresis; Polyarteritis Nodosa; Prednisone | 2001 |
Real-time PCR for detection and quantitation of hepatitis B virus DNA.
Topics: Acute Disease; Antiviral Agents; Computers; DNA, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity | 2001 |
Acute hepatitis B by sexual transmission after interruption of lamivudine-containing antiretroviral regimen.
Topics: Acute Disease; Adult; Anti-HIV Agents; Coitus; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Pregnancy; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral | 2001 |
Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir.
Topics: Acute Disease; Adenine; Adult; Anti-HIV Agents; Drug Resistance, Viral; Graft Rejection; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Immunohistochemistry; Lamivudine; Liver; Liver Transplantation; Male; Organophosphonates | 2001 |
Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases.
Topics: Acute Disease; Adult; Aged; Child; Cross Infection; Disease Outbreaks; Fatal Outcome; Female; Hematologic Diseases; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Failure | 2001 |
Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Recurrence; Virus Activation | 2002 |
Lamivudine treatment for recurrent pancreatitis associated with reactivation of chronic B hepatitis.
Topics: Acute Disease; Adult; Antiviral Agents; Hepatitis B, Chronic; Humans; Lamivudine; Male; Pancreatitis; Recurrence; Tomography, X-Ray Computed | 2002 |
Needlestick transmission of hepatitis C.
Topics: Accidents, Occupational; Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Asthenia; Exanthema; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Internship and Residency; Lamivudine; Needlestick Injuries; Nelfinavir; Occupational Exposure; Physicians; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Zidovudine | 2002 |
A case of flare syndrome.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Ganciclovir; HIV Infections; Humans; Indinavir; Lamivudine; Male; Organophosphonates; Organophosphorus Compounds; Zidovudine | 2001 |
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
Topics: Acute Disease; Adolescent; Antineoplastic Agents; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation | 2002 |